Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Spnib 50mg Tablet
Manufacturer/Marketed By : ZYDUS CADILA
$37.31 $33.58
Sidmex Inovia offers bulk export supply of Spnib 50mg Tablet (DASATINIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
DASATINIB
Active Pharmaceutical Ingredient
Spnib 50mg Tablet
$37.31
$33.58
Sidmex Inovia offers bulk export supply of Spnib 50mg Tablet (DASATINIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Spnib 50mg Tablet contains the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia (CML). This medicine is also used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia in the chronic phase and Ph+ acute lymphoblastic leukemia (ALL) in patients who are resistant to other therapies. Chronic Myeloid Leukemia is a form of blood cancer where the body produces too many white blood cells due to changes in the Philadelphia chromosome. On the other hand, Acute Lymphoblastic Leukemia is a blood cancer most common in children, where lymphocytes multiply abnormally fast and survive longer than usual. The Spnib 50 mg tablet price and Spnib 50 mg price in India can differ depending on the medical store, location, and availability. Patients looking for convenience can also buy Spnib 50 mg tablet online from trusted and licensed medical platforms with a valid prescription. The primary Spnib 50 mg uses include treating CML and ALL effectively. Your doctor will determine the right Spnib 50 mg dosage according to your health condition, treatment stage, and response to the medicine. This medicine is produced by a reliable Spnib 50 mg manufacturer, and the Spnib 50 mg tablet composition includes Dasatinib as the active ingredient. For patients in India, Spnib 50 mg availability in India ensures access through both local pharmacies and online suppliers.
Active Pharmaceutical Ingredient
Uses
• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. spnib 50 mg side effects are
Most Common Side Effects
• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP
Common Side Effects
• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction
How To Use
Take the tablet with or without food at the same time each day. Do not break, crush or chew the tablet. Your doctor will decide the dose and frequency of Spnib 50mg tablet administration based on your disease severity and other factors. Do not stop taking the tablet without consulting your healthcare professional.
Safety Advice
• Breast Feeding: It is not recommended to breastfeed while taking Spnib 50mg tablet as it is unknown whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.
• Alcohol: It is not known whether it is safe to consume alcohol with Spnib 50mg tablet. Consult your doctor for advice.
• Liver: Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.
• Lungs: It is unknown whether Spnib 50mg tablet is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.
• Driving: Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness.
• Pregnancy: Spnib 50mg tablet is not recommended during pregnancy unless necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.